3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Myelodysplastic Syndromes
1
Leukemia, Promyelocytic, Acute
1
Leukemia, Myeloid, Acute
1
Interventions
Cytarabine
16
Arsenic Trioxide
11
Tretinoin
10
Methotrexate
10
Cyclophosphamide
9
Idarubicin
8
Filgrastim
7
Mercaptopurine
6
Busulfan
6
fludarabine phosphate
5
Etoposide
5
Vorinostat
4
Topotecan
4
Sorafenib
4
Radiotherapy
4
Peripheral Blood Stem Cell Transplantation
4
Daunorubicin
4
Clofarabine
4
Granulocyte Colony-Stimulating Factor
3
Gemtuzumab
3
Azacitidine
3
Antilymphocyte Serum
3
romidepsin
2
merphos
2
lintuzumab
2
entinostat
2
Thiotepa
2
Tacrolimus
2
Mitoxantrone
2
Lenalidomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Leukemia, Promyelocytic, Acute
×
tamibarotene
×
Clear all
NCT00520208
2013-02-13
STAR-1
CytRx
Phase 2
Completed
15 enrolled